◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Avicanna Inc. (AVCN) Financial History

Name: Avicanna Inc. (AVCN) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-16

Avicanna Inc. (AVCN) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Toronto, Canada with about 112 employees. Its market capitalization is roughly CAD 17 million. In the fiscal year ended 2025-12-31, AVCN reported CAD 26M in revenue and (CAD 3M) in net income.

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally.

Interactive charts & full statements →

AVCN Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CAD 26M	CAD 26M	CAD 17M	CAD 4M	—
Gross Profit	CAD 14M	CAD 12M	CAD 7M	CAD 1M	—
Operating Income (EBIT)	(CAD 3M)	(CAD 6M)	(CAD 8M)	(CAD 10M)	—
Net Income	(CAD 3M)	(CAD 4M)	(CAD 9M)	(CAD 15M)	—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AVCN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	CAD 7M	CAD 7M	CAD 6M	CAD 6M	CAD 6M	—
Gross Profit	CAD 4M	CAD 4M	CAD 3M	CAD 3M	CAD 4M	—
Operating Income (EBIT)	(CAD 0M)	(CAD 1M)	(CAD 1M)	(CAD 1M)	CAD 0M	—
Net Income	(CAD 0M)	(CAD 1M)	(CAD 1M)	(CAD 1M)	CAD 0M	—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AVCN Free Cash Flow History

AVCN Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CAD 21M	CAD 19M	CAD 22M	CAD 18M	—
Total Liabilities	CAD 10M	CAD 10M	CAD 14M	CAD 14M	—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AVCN viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

RMTI · Rockwell Medical, Inc. — $28 million
1889 · Sanai Health Industry Group Company Limited — $26 million
AYTU · Aytu BioPharma, Inc. — $26 million
TXMD · TherapeuticsMD, Inc. — $24 million
BFRI · Biofrontera Inc. — $17 million
B8FK · Biofrontera AG — $15 million
CABR · Caring Brands, Inc. — $13 million
INM · InMed Pharmaceuticals Inc. — $8 million

← AVBP All “A” companies AVD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.